| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.0055 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.0039 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |